Intellia Therapeutics (NASDAQ:NTLA) Shares Down 5.8% – What’s Next?

Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) fell 5.8% during trading on Tuesday . The stock traded as low as $15.36 and last traded at $15.40. 1,366,835 shares traded hands during mid-day trading, a decline of 15% from the average session volume of 1,607,717 shares. The stock had previously closed at $16.34. Analysts Set […]

Leave a Reply

Your email address will not be published.

Previous post Falcon’s Beyond Global (NASDAQ:FBYD) Shares Gap Up – Should You Buy?
Next post CATCo Reinsurance Opportunities Fund (LON:CAT) Reaches New 52-Week High – Should You Buy?